Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3706_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
33 Мб
Скачать
26 The Charcot Foot inDiabetes
https://t.me/med1917
481
processes are not yet rmly established, bisphosphonates have been postulated as having a role in both syndromes for different reasons. Bisphosphonates inhibit bone resorption by osteoclasts in osteoporosis or in Charcot fractures with mixed data in response to bisphosphonate therapy [3945]. Jeffcoate has also suggested that a dysregulation of the RANK-L (receptor activator of nuclear factor kappa B ligand)/OPG (osteoprotegerin) signaling pathway resulting from a disproportionate release of pro-inammatory and anti-inammatory cytokines and attendant effects on blood ow and bone turnover might also play a role in this regard [3, 4648]. Inammation stimulates osteoclastogenesis com­bined with mechanical force through gait on the neuropathic foot, ultimately disrupting the pedal architecture. Further study is required, however, to determine how these pathways interact in patients with neuropathy to cause increased vas­cularity and subsequent osteopenia.
Clinical Presentation
The classic presentation for the active Charcot foot includes several characteristic clinical ndings which are summarized in Table26.1. Typically, the patient with a Charcot foot will have had a long duration of diabetes, usually in excess of 12years. Although all age groups can be affected, a review of the literature in this regard indicates that the majority of patients are in their sixth decade (mid-50s) [28, 49]. A more recent report, however, indicates that there is an apparent age difference in onset of patients with type 1 and type 2 diabetes [50]. Whereas the average age at presentation for the entire cohort and type 2 diabetes patients is indeed in the sixth decade, for type 1 diabetes patients, the age at onset was in
the fth decade (40s). Patients with type 1 diabetes also dem­onstrated a longer duration of the disease than in type 2 dia­betes patients with osteoarthropathy (24 vs. 13years) [50]. This has also been corroborated by an earlier report from Finland [51]. While unilateral involvement is the most fre­quent presentation, bilateral Charcot foot can be found in 9–18% of patients [7, 17], although in the author’s experi­ence, rarely does active Charcot foot present bilaterally.
The initial presentation for active Charcot arthropathy is usually quite distinct in that a patient will seek attention for a profoundly swollen foot that is difcult to t into a shoe (Fig. 26.3). Although classically described as painless, 75% of these patients will complain of pain or aching in an otherwise insensate foot [17]. Frequently, an antecedent history of some type of injury can be elicited from the patient [34]. When no such history is available, the precipi­tating event might simply have gone unrecognized in the neuropathic limb.
On examination, the pulses will be characteristically bounding even through the grossly edematous foot [28, 52]. Occasionally, however, the swelling will obscure one or both pedal pulses. In concert with the hyperemic response to
Table 26.1 Clinical features of an acute are or active Charcot foot
Osseous Vascular Nerve Integument Rocker-bottom
deformity
Subluxation of the midfoot or hindfoot Digital subluxation
Rearfoot equinovarus
Ankle varus Light touch
Joint crepitus Anhidrosis Joint hypermobility
Increased or bounding pedal pulses
Erythema Pain Hyperkeratosis
Edema Absent or poor
Calor Decreased or
Absent or diminished protective sensation
vibratory testing
absent deep tendon reexes
sensation diminished
Neuropathic pressure ulcer
Infection
Gangrene
Xerosis
Fig. 26.3 Acute Charcot ankle with profound foot and leg edema
482
https://t.me/med1917
L. C. Rogers et al.
injury, the foot will also be somewhat erythematous and warmer or hot in relation to the contralateral foot. The skin temperature elevation can be ascertained by dermal infrared thermometry or thermography and will contrast with the unaffected side by 3–8°C (Fig.26.4) [17, 49, 51, 5358]. There is always some degree of sensory neuropathy in which reexes, vibratory sense, proprioception, light touch, and pain (pin prick) are diminished or absent. Motor neuropathy can present as a foot drop deformity or intrinsic muscle atro­phy. Ankle equinus can sometimes be ascertained initially but may be difcult to perceive if there is gross osseous deformity and laxity in the midfoot. Clinical exam is para­mount to determine if equinus is present secondary to Achilles contracture or osseous bony block at the ankle. Autonomic neuropathy, which coexists with somatosensory neuropathy in diabetes, can be clinically appreciated by the presence of anhidrosis with very dry skin and/or callus for­mation or by measuring heart rate variability with deep breathing [25, 26]. Although more common in the chronic or inactive Charcot foot, plantar ulceration might be evident on initial presentation. A concomitant ulceration will therefore raise questions of potential contiguous soft tissue infection or suspicion of osteomyelitis [28, 33, 52].
The skeletal changes frequently manifest as obvious deformity of the midfoot with collapse of the arch and/or rocker-bottom deformity (Fig.26.5) [33, 49]. Midfoot col­lapse can be attributed to the medial or lateral foot (or both) and is a prognostic factor in healing, recurrence, and severity
a
Fig. 26.4 Thermograph of the plantar feet with signicant temperature difference, indicating active midfoot Charcot process of the right foot
b
Fig. 26.5 (a) Clinical image of a chronic lateral midfoot ulcer associ- ated with a rocker-bottom deformity. (b) Radiograph of same patient showing severe rearfoot equinus with absence of heel purchase, nega­tive calcaneal inclination angle, and midfoot arthropathy with deformity
26 The Charcot Foot inDiabetes
https://t.me/med1917
of deformity [51, 52]. Associated ndings might often include hypermobility with crepitus, signicant instability, and ankle deformity.
Diagnosis ofActive Charcot Foot
The diagnosis of active Charcot foot is primarily based on history and clinical ndings. Standard radiographs should always be performed. Weight-bearing X-rays are most help­ful in evaluating subluxations and angular deformities. Contralateral X-rays (or previous X-rays) for comparison might make subtle subluxations more evident. Advanced imaging can help conrm diagnosis in complicated scenarios or when the index of suspicion for the disorder is high in the presence of an ostensibly normal X-ray. Inammation plays a key role in the pathophysiology and is the earliest exam nding [53, 59]. When presented with a warm, swollen, insensate foot, plain radiographs are invaluable in ascertain­ing the presence of osteoarthropathy and the degree [28, 60]. In most cases, no further imaging studies will be required to make the correct diagnosis. However, in the active, prodro­mal “stage 0” of Charcot foot, there may be primarily soft tissue changes noted without X-ray evidence of distinct bone or joint pathology [61, 62]. Further investigation with MRI, serial radiographs, or scintigraphy should be considered when suspicion is high for osteoarthropathy or concomitant wound to investigate for osteomyelitis [6367]. Admittedly, differentiating between acute Charcot arthropathy, acute gout, and osteomyelitis solely based on plain radiographs can be difcult [68]. Additional laboratory studies may prove useful in determining the appropriate diagnosis. Leukocytosis can often suggest acute osteomyelitis; however, this normal response to infection can be blunted in persons with diabetes or autoimmune disorders [68, 69]. While the erythrocyte sedimentation rate (ESR) may also be elevated in the case of gout or acute infection, it often responds similarly to any inammatory process and is therefore nonspecic. Similarly, C-reactive protein (CRP) is an inammatory marker but rises in hours and thus can be trended in an acute window directly monitoring for inammation or infection and can be utilized to monitor therapy response as it is often elevated for only 3–7days [70]. Neither lab tests have been determined to be superior and are likely to yield concordant results [70]. Comparably, procalcitonin is a biologic serum marker also detectable within hours and peaks earlier than ESR and CRP, within 1day, and is not elevated in noninfectious inamma­tory conditions. Procalcitonin can be helpful in trending bac­terial infections or sepsis and in a systematic review was noted to be more sensitive, more specic, and more accurate in differentiating inammation due to infection versus non-
483
Fig. 26.6 Light micrograph of a pathology slide of the bone from an active neuroarthropathic foot (100×, decalcied, H&E stain). Note the center trabeculum has incongruous edges with osteoclasts (solid arrow), many inammatory cells, and trabecular fragmentation (broken arrows)
infectious cases and furthermore differentiating bacterial versus viral causes [71, 72]. All three inammatory markers can predict severity of infection and anticipated hospital duration [7174].
When a foot ulcer probes to the bone, a bone biopsy is recommended to formally diagnose osteomyelitis [28, 75,
76]. A biopsy consisting of multiple shards of bone and soft
tissue embedded in the deep layers of synovium is pathogno­monic for neuroarthropathy (Fig.26.6) [77].
Radiographic Imaging
Radiographically, osteoarthropathy takes on the appearance of a severely destructive form of degenerative arthritis. Serial radiographs customarily demonstrate changes occurring throughout the process and can assist in monitoring disease activity [75]. Occasionally, nucleotide scanning, CT, or MRI may be necessary to establish the diagnosis. The acute or devel­opmental stage is marked by an abundance of soft tissue edema, osteopenia, multiple fractures, loose bodies, subluxation, or dislocation [33, 7880]. These radiographic ndings are fairly typical of noninfective bone changes associated with diabetes and have been described well by Newman [81]. In addition to alterations in the normal pedal architecture, the metatarsal heads and phalanges can demonstrate atrophic changes referred to as diabetic osteolysis. Synonyms for this phenomenon include a “sucked candy” appearance, “pencil pointing,” “hour­glass” deformities of the phalanges, or “mortar and pestle” deformity of the metatarsophalangeal joints [81, 82]. Massive osteolysis can also occur in the rearfoot during the acute stage, especially in the ankle and subtalar joints (Fig.26.7).
484
bd
https://t.me/med1917
L. C. Rogers et al.
Fig. 26.7 (a–d) Osteolysis of the talus with disintegration of the ankle, subtalar, and calcaneal-cuboid joints. Distention of the hindfoot joints lled with synovial uid and dissolved periarticular structures
a
c
These changes will often coexist with the obvious frac­tures initiated by the destructive process. Another associated nding in Charcot arthropathy is medial arterial calcication (Fig.26.8) [25].
Chronic reparative or quiescent radiographic changes include hypertrophic changes such as new periosteal bone formation, coalescence of fractures and bony fragments, sclerosis, remineralization, and reduction in soft tissue edema [28, 49, 83]. Rocker-bottom deformities, calcaneal equinus, dropped or negative cuboid, or other deformities not previously appreciated may also become visible, especially in weight-bearing images. Lateral weight-bearing foot radiographs are invaluable since they show two important
bearing foot X-ray) should be unbroken (Fig. 26.9). Table26.2 summarizes the varieties of radiographic changes found in neuroarthropathy.
Sanders and Frykberg described radiographic patterns of joint involvement based upon joint location [49]. These pat­terns may exist independently or in combination with each other as determined through clinical and radiographic nd­ings. They are illustrated in Fig.26.10 and described as fol­lows: Pattern I, forefoot-metatarsal-phalangeal joints; Pattern II, tarsometatarsal (Lisfranc’s) joint; Pattern III, midtarsal and navicular-cuneiform joints; Pattern IV, ankle and subta­lar joints; and Pattern V, calcaneus (calcaneal insufciency avulsion fracture) [32, 33, 49].
radiographic features of Charcot foot deformities, the calca­neal inclination angle and the talo-rst metatarsal relation­ship. The calcaneal inclination angle (normally 20°) is often reduced or in severe deformity as a declination (negative angle). The lateral talo-rst metatarsal relationship (a line bisecting the talus and the rst metatarsal on lateral weight-
Pattern I: Forefoot
Pattern I encompasses atrophic changes or osteolysis of the metatarsophalangeal and interphalangeal joints with the characteristic sucked candy appearance of the distal metatar­sals [52, 80]. Frequently, atrophic bone resorption of the dis-
26 The Charcot Foot inDiabetes
https://t.me/med1917
485
Fig. 26.9 Lateral weight-bearing radiographs of a patient before (top) and after (below) the development of a rocker-bottom deformity with midfoot collapse. The calcaneal inclination angle (white) has signi­cantly decreased, and the talo-rst metatarsal relationship (black) is broken and abnormal
Fig. 26.8 Calcication of the vascular intima media or Monckeberg’s sclerosis can be seen in many patients with Charcot foot and patients with diabetes. In this lateral radiograph, the anterior tibial artery as it transitions to the dorsalis pedis artery (solid arrow) and the posterior tibial arteries are visible on plain radiograph due to vessel calcications
tal metatarsals and phalanges accompanies other changes found in the midfoot and rearfoot. An infectious etiology has been proposed for these ndings although osteolysis can occur without any prior history of joint sepsis. Reports of 10–30% of the neuroarthropathies have been categorized as Pattern I [5, 17, 49, 66, 68, 82].
Pattern II: Tarsometatarsal (Lisfranc’s) Joint
Pattern II involves Lisfranc’s joint, typically with the earliest clue being a very subtle lateral deviation of the base of the second metatarsal at the cuneiform joint. Once the stability of this “keystone” is lost, the Lisfranc’s joint complex will often subluxate dorsolaterally. Fracture of the second meta­tarsal base allows for greater mobility in which subluxation of the metatarsal bases will occur with appreciable diastasis of the joint. The rupture of intermetatarsal and tarsometatar­sal ligaments plantarly permits collapse of the arch during normal weight-bearing, leading to the classic rocker-bottom deformity. Compensatory contracture of the triceps surae will frequently follow and create a further plantarexory
Table 26.2
Stage Atrophic changes Active Osteolysis—
Inactive Distal metatarsal
Radiographic changes in neuroarthropathy
Hypertrophic changes Miscellaneous
resorption of bone
Metatarsal heads, phalangeal diaphyses, MTP, subtalar, ankle
Osteopenia
and rearfoot osteolysis Bone loss
Periosteal new bone Intra-articular debris, joint mice, fragments Osteophytes, architectural collapse, deformity
Periosteal new bone Marginal osteophytes Fracture bone callus Rocker bottom Midfoot or ankle deformity Ankylosis
Joint effusions Subluxations Fractures
Soft tissue edema Medial arterial calcication Ulceration
Resorption of debris Diminished edema Sclerosis
Ulceration
moment to accentuate the inverted arch as compensation decreases [84, 85]. This pattern also is commonly associated with plantar ulcerations at the apex of the collapse, which typically involves the cuboid or cuneiforms due to progres­sive midfoot collapse due to midfoot hypermobility and liga­ment attenuation, forefoot abduction, metatarsus primus
486
The High Risk Foot in Diabetes Mellitus
III.
https://t.me/med1917
L. C. Rogers et al.
I.
IPJ’s & Phalanges MTPJ’s & Metatarsals
Ulceration
NC Joints TN & CC Joints
II.
IV.
TMT Joints
Ulceration
Ankle Joints
V.
Calcaneus
KEY:
IPJ’s
MTPJ’s
TMT
NC
TN
CC
= Interphalangeal joint
= Metacarpophalangeal joint
= Tarsometatarsal
= Naviculocuneiform
= Talonavicular
= calcaneocuboid
Fig. 26.10 Patterns of diabetic osteoarthropathy can be classied based on anatomic involvement. (From Sanders LJ, Frykberg RG.The Charcot foot. In: Frykberg RG, editor. The high-risk foot in diabetes mellitus. NewYork: Churchill Linvingston; 1991. p.325–35, with permission)
26 The Charcot Foot inDiabetes
https://t.me/med1917
487
varus, and hallux valgus (Chap. 11) [28, 49, 8486]. This was the most frequent pattern of presentation for diabetic Charcot feet in the Sinha series and represents the most com­mon presentation in clinical practice, with an occurrence of 40% [7, 80, 82].
Pattern III: Midtarsal and Naviculocuneiform Joints
Pattern III incorporates changes within the midtarsal (Chopart’s) joint being the talonavicular and calcaneocuboid joints with the frequent addition of the naviculocuneiform joint. As described by Newman and Lesko and Maurer, spon­taneous dislocation of the talonavicular joint with or without fragmentation characterizes this pattern [81, 87, 88].
Newman further suggested that isolated talonavicular joint subluxation might even be considered as an entity sepa­rate from osteoarthropathy, although still an important ele­ment of noninfective neuropathic bone disease [81]. Lisfranc’s joint changes (Pattern II) are often seen in combi­nation with Pattern III deformities of the lesser tarsus, together contributing up to 70% of all pathologic patterns of Charcot foot [80].
Pattern IV: Ankle andSubtalar Joint
Pattern IV involves the ankle joint, subtalar joint, and body of the talus. Disintegration of the talar body is equivalent to the central tarsal disintegration of Harris and Brand [88]. The destructive forces are created by joint incongruity and con­tinued mechanical stress which eventually erodes the talus and periarticular surfaces. Massive osteolysis is frequently observed in this pattern with attendant ankle or subtalar joint subluxation and angular deformity, often with concomitant ulceration. As noted, tibia or bular malleolar fractures are frequently seen in association with neuroarthropathy in this location and most likely precipitated by the development of joint dissolution. Pattern IV Charcot is found in approxi­mately 10% of reported cases [7, 49, 80].
Pattern V: Calcaneus (Calcaneal Insuciency Avulsion Fracture)
Pattern V, the least common presentation (~2–5%), is charac­terized by extra-articular fractures of the calcaneus (poste­rior pillar) [2, 80]. This extra-articular fracture is included in the neuropathic osteoarthropathy classication; however, there is no joint involvement (Fig. 26.15). This is more appropriately considered as a neuropathic fracture of the body or, more commonly, the posterior tuberosity of the cal­caneus. Kathol and El-Khoury [89, 90] have termed this entity the “calcaneal insufciency avulsion fracture.”
Advanced Imaging
Technetium (Tc99) three-phase bone scans are exquisitely sensitive for detecting Charcot arthropathy but are generally nonspecic in assisting in the differentiation between osteo­myelitis and acute neuroarthropathy [63, 91, 92]. Indium (In111) scanning has been shown to be more specic for infection; however, false-positive scans can be frequently observed in rapidly evolving acute osteoarthropathy without associated osteomyelitis [65, 9294]. Additional studies helpful in differentiating Charcot arthropathy from osteomy­elitis include Tc-HMPAO labeled white blood cell scans and magnetic resonance imaging [64, 91, 95, 96].
MRI examination can be very sensitive to the earliest changes in neuroarthropathy but, again, is not reliable in detecting bone infection superimposed upon the gross changes noted surrounding a Charcot joint [64, 68, 91, 95,
96]. Morrison suggests the consideration of “secondary
signs” of osteomyelitis on MRI may help the clinician dis­cern between Charcot foot and osteomyelitis [97]. Table 26.3 lists the secondary signs of Charcot foot and osteomyelitis [97].
Another imaging modality that may show some promise in this regard is positron emission tomography (PET) [98,
99]. Hopfner and colleagues reported that this modality
could not only detect early osteoarthropathy with 95% sensi­tivity but could also reliably distinguish between Charcot arthropathy and osteomyelitis even in the presence of implanted hardware [100]. However, no study is 100% accu­rate in distinguishing neuropathic bone lesions from infec­tious entities. Therefore, clinical acumen is necessary for detecting Charcot arthropathy at its onset, and clinical judg­ment remains paramount in properly assessing and manag­ing these patients. Rogers and Bevilacqua presented a simplied algorithm based on imaging studies to help dif­ferentiate Charcot foot from osteomyelitis (Fig.26.11) [68]. The management can therefore be extrapolated based on risk factors, level of injury, and level of instability [101].
Table 26.3 Comparing “secondary signs” of Charcot foot and osteo­myelitis on magnetic resonance imaging (MRI)
Charcot foot Osteomyelitis
Characteristic No visible track to
bone Primarily affects midfoot Multiple bones involved Deformity is common
Visible track from skin to bone Primarily affect forefoot and rearfoot Usually only one bone affected Deformity is uncommon
488
https://t.me/med1917
Fig. 26.11 Standard imaging studies to aid in differentiating Charcot foot from osteomyelitis. (From Rogers LC, Bevilacqua NJ.Imaging of the Charcot foot. Clin Podiatr Med Surg. 2008;25(2):263–274, vii., with permission)
L. C. Rogers et al.
Clinical Suspicion
of Charcot Foot
Bone destruction
on x-ray?
99Tc bone
scan
(–)
NO
CHARCOT
or OM
Classication ofCharcot Arthropathy
The Eichenholtz classication is one of the earliest classi­cations for Charcot joints and is based on the radiographic evidence of joint pathology. Eichenholtz divided osteoar­thropathy into developmental, coalescence, and reconstruc­tive stages [83]. Several other authors have subsequently proposed an earlier “Stage 0” that corresponds to the initial inammatory period following injury but prior to the devel­opment of any characteristic bony radiographic changes [61,
67, 102].
This prodromal period might be considered as “osteoar­thropathy in situ” stage. The traditional developmental stage, stage I, is characterized by fractures, debris formation, and fragmentation of cartilage and subchondral bone. This is fol­lowed by capsular distension, ligamentous laxity, varying degrees of subluxation, and marked soft tissue swelling. Synovial biopsy at this time will show osseous and cartilagi­nous debris embedded in a thickened synovium, which is pathognomonic for the disease [83]. The coalescence stage, stage II, is marked by the absorption of much of the ne debris, a reduction in soft tissue swelling, bone callus prolif­eration, and consolidation of fractures. Finally, the recon-
(+)
Ye s
CHARCOT
Open wound?
Ye s
No
CHARCOT
MRI,*
111 In, or
99mTc
HMPAO
(–)
(+)
OM or
Charcot +
OM
No
structive stage, stage III, is denoted by bony ankylosis and hypertrophic proliferation with some restoration of stability. In certain cases, however, severe osseous disintegration occurs due to prolonged activity resulting in permanent deformity of the foot and/or ankle. In these situations, the condition may be referred to as chronically active, and little healing, if any, takes place and is termed in remission [76]. While the system is radiologically very descriptive and use­ful, its practical clinical applicability is less so. In clinical practice, the initial developmental stage is considered active or acute, while the coalescent and reconstructive stages are considered to be the inactive or quiescent stages. Other clas­sication systems have been described based upon anatomic sites of involvement but do not describe the activity of the disease [61, 88, 103105]. Rogers and Bevilacqua described a prognostic staging system based on anatomic location and complicating factors of the Charcot joint (Fig.26.12) [105,
106], which was later validated as prognostic for amputation
by Viswanathan etal. in a group of 53 patients [107]. The Sanders and Frykberg classication is descriptive, based on the site of involvement, and was described in detail above [49]. None of the above detail absolute treatment interven­tion in regards to time or procedure.
Classifying Charcot Arthropahy
(more complicated)
pressure
(less contact
2
26 The Charcot Foot inDiabetes
https://t.me/med1917
489
(more proximal)
Location and
Stage
A. Acute
Charcot without deformity
B. Charcot
with deformity
C. Charcot
with deformity and ulceration
D. Charcot
with osteomyelitis
Fig. 26.12 Rogers and Bevilacqua dual axis classication of Charcot foot amputation risk based upon location and complications
1. Forefoot 2. Midfoot
Low Risk of Extremity Amputation
3. Rearfoot/
Ankle
High Risk of Extremity Amputation
The American Diabetes Association and American Podiatric Medical Association created the Joint Task Force on the Charcot Foot comprised of a multinational group of Charcot foot experts in 2010. Given the confusion about classications, their limited prognostic value, and inability to direct treatment, the Joint Task Force recommended simplifying the clinical classication of the Charcot foot to active or inactive based on the presence of inammation [59]. Subsequently, the International Working Group on the Diabetic Foot (IWGDF) provided updated guidelines on the diagnosis and treatment of Charcot neuro-osteoarthropathy in 2023 [108].
tive impairment and increased risk of falls with ofoading treatment. Since total non-weight-bearing is frequently unattainable for many patients in this category, total contact cast (TCC) may serve as a useful alternative and is the most effective form of ofoading while bearing weight [109,
112]. TCC can be applied safely in those with Charcot foot
but should be changed frequently at rst since edema tends to reduce greatly with immobilization and ofoading which will lead to a poorly tting cast [59]. Fig.26.13 shows the major mechanisms of action of a total contact cast in reliev­ing plantar pressure and immobilizing the foot and ankle. A TCC is effective at reducing plantar pressures by approxi­mately 30% [110, 111]. In those patients where a TCC can­not be used, a soft compressive dressing or Unna’s boot in concert with a removable cast walker or pneumatic walking brace can also be used secondarily in this regard [33]. However, a large study in the UK found that patients using removable devices took signicantly longer to heal versus the TCC group [20]. In the presence of ulcers or infections, frequent debridement and careful observation are required. Charcot neuropathic osteoarthropathy can take weeks to months to reach remission, and ofoading with immobiliza­tion should be anticipated for approximately 6months or more, depending on the severity of joint destruction [113]. Conversion to the inactive/reparative phase is heralded by a reduction in pedal temperature to within 4°F (2.5 °C) of that of the unaffected side and a sustained reduction in edema [17].
Medical Management
Ooading
Immobilization and reduction of stress are considered the most important initial treatment for active Charcot arthropa­thy [28, 59, 109111]. Effective ofoading or complete non- weight- bearing on the affected limb removes the con­tinual trauma and should promote conversion of the active Charcot joint to the inactive quiescent phase [28, 51, 78]. Non- weight- bearing is an accepted form of ofoading for most foot and ankle injuries; however, three point crutch gait may increase pressure to the contralateral limb, thereby predisposing it to repetitive stress and ulceration or an active Charcot episode [87]. Additionally, those with diabetic neu­ropathy tend to be older and overweight and do not have the cardiovascular reserve for the additional energy required to use crutches effectively. A patient with neuropathy severe enough to lead to a Charcot foot will also have propriocep-
Shape
of the
leg
Eliminated
3
ankle
motion
Reduced
plantar
Fig. 26.13 An image of a total contact cast (TCC) depicting the major mechanisms of action in ofoading and immobilization
Transferred
1
weight to the
4
5
tibia
Shortened
stride length
time on the
ground)
Fewer steps
per day
490
https://t.me/med1917
This should be corroborated with serial radiographs indi­cating consolidation of osseous debris, union of fractures, a reduction in soft tissue edema, and no progression of defor­mity. McGill etal. have found a reduction in skin tempera­ture and bone scan activity that mirrors activity of Charcot neuroarthropathy, both of which improve as the condition achieves the inactive stage or quiescence [54].
When the patient enters the inactive stage, management is directed at a gradual resumption of weight-bearing with pro­longed or permanent bracing [17, 28, 59]. Care must be taken to gradually titrate the patient from non-weight- bearing (or TCC) to partial to full weight-bearing with the use of assistive devices (i.e., crutches, cane, or walker). Progression to protected weight-bearing is permitted, usually with the aid of some type of ambulatory, immobilizing device [112]. Charcot restraint orthotic walkers (CROW) or other similar total contact prosthetic walkers have gained acceptance as useful protective modalities for the initial period of weight­bearing after TCC or surgical reconstruction [114]. These custom-made braces usually incorporate some degree of patellar tendon bearing as well as a custom footbed with a rocker sole. A more readily available option is a pneumatic walking brace or similar removable cast walker that might incorporate a cushioned footbed or insole. These can be made less removable or nonremovable by simply applying adhesive tape or cast bandaging around the body of the brace to help encourage compliance (Fig.26.14) [115, 116].
The mean time of rest and immobilization (casting fol­lowed by removable cast walker) prior to return to perma­nent protective footwear is approximately 4–12months [17,
20, 51]. Feet must be closely monitored during the time of
transition to permanent footwear to insure that the acute inammatory process does not recur. Forefoot and midfoot deformities often do well with custom full-length inserts and comfort or extra-depth shoes once bracing is no longer required [28].
Continuing effective ofoading with non-custom bracing or TCC often serves as interim footwear prior to obtaining permanent custom-made footwear. Severe midfoot deformi­ties will often require the fabrication of custom shoes to accommodate the misshapen foot. Rearfoot neuroarthropa­thy with minimal deformity may require only a deep, well­cushioned shoe with a full-length orthotic device. For mildly unstable ankles without severe deformity or joint dissolu­tion, high-top custom shoes can sometimes provide adequate stability against transverse plane rotational forces. The mod­erately unstable ankle will benet from an ankle foot ortho­sis (AFO) and a high-top therapeutic shoe. The severely unstable or maligned rearfoot will require a patellar tendon bearing (PTB) brace incorporated into a custom shoe [116,
117]. The PTB brace has reportedly decreased the rearfoot
mean peak forces by at least 32% [117].
L. C. Rogers et al.
Fig. 26.14 A removable cast walker (RCW) rendered “less remov­able” with an external layer of cohesive bandage. Alternatively, ber­glass has be used
Antiresorptive Therapy
In the setting of altered bone mineral density (BMD) in patients with diabetes and neuropathy, there has been interest in the adjunctive use of bisphosphonate therapy in acute Charcot arthropathy [31, 39, 118, 119]. However, further study has cast a negative shadow on their routine use for Charcot foot [20], and it was not recommended by the Joint Task Force [59]. These pyrophosphate analogs are potent inhibitors of osteoclastic bone resorption and are widely used in the treatment of osteoporosis, Paget’s disease, and reex sympathetic dystrophy syndrome. Although one uncontrolled study of six patients found sig­nicant reductions in foot temperature and alkaline phos­phatase levels as compared to baseline, its small size and lack of a control group preclude making any meaningful conclusions from the treatment [119]. A subsequent multi-